Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors

Francis Chaouloff, Alexander Kulikov, Pierre Mormède
European Journal of Pharmacology. 1997-09-01; 334(1): 25-29
DOI: 10.1016/s0014-2999(97)01197-7


Auteurs Bordeaux Neurocampus